Day: 6 July 2020

Series C

Missin Therapeutics secures £12 million Series C investment led by

Mission Raises $15m and Expands its Relationship with Pfizer CAMBRIDGE, UK– 6 July 2020 – Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that it has raised $15m (£12m) in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer Inc. (“Pfizer”)(NYSE: PFE). […]Read More

Original

BotsAndUs secures £4.8 million Series A investment led by Kindred

BotsAndUs secures $6m, to continue its mission to bring autonomous robotics into everyday environments BotsAndUs’ autonomous robotics solutions are designed for indoor, dynamic, public spaces. They are the engine for real-time data that automates customer service and operations to reduce costs, increase sales, optimise compliance and boost customer satisfaction. The company is already working with […]Read More